PDA is working to assemble a team of subject matters experts to address issues of downstream drug distribution as they arise. This might include commenting on regulations and guidance's relating to distribution issues, reviewing our current Technical Reports on distribution to identify any necessary updates, and assisting other PDA teams when particular insight is needed. This team may meet by teleconference when necessary but will primarily communicate by email.
We respect your privacy